The DOI matches its Crossref record; 19 of the 21 references it cites were found in a registry or an index.
Effect of Coenzyme Q10 Supplementation on Simvastatin-Induced Myalgia
Abstract
Myalgia is the most frequently reported adverse side effect associated with statin therapy and often necessitates reduction in dose, or the cessation of therapy, compromising cardiovascular risk management. One postulated mechanism for statin-related myalgia is mitochondrial dysfunction through the depletion of coenzyme Q(10), a key component of the mitochondrial electron transport chain. This pilot study evaluated the effect of coenzyme Q(10) supplementation on statin tolerance and myalgia in patients with previous statin-related myalgia. Forty-four patients were randomized to coenzyme Q(10) (200 mg/day) or placebo for 12 weeks in combination with upward dose titration of simvastatin from 10 mg/day, doubling every 4 weeks if tolerated to a maximum of 40 mg/day. Patients experiencing significant myalgia reduced their statin dose or discontinued treatment. Myalgia was assessed using a visual analogue scale. There was no difference between combined therapy and statin alone in the myalgia score change (median 6.0 [interquartile range 2.1 to 8.8] vs 2.3 [0 to 12.8], p = 0.63), in the number of patients tolerating simvastatin 40 mg/day (16 of 22 [73%] with coenzyme Q(10) vs 13 of 22 [59%] with placebo, p = 0.34), or in the number of patients remaining on therapy (16 of 22 [73%] with coenzyme Q(10) vs 18 of 22 [82%] with placebo, p = 0.47). In conclusion, coenzyme Q(10) supplementation did not improve statin tolerance or myalgia, although further studies are warranted.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Seven studies with 321 patients were included in the pooled analysis, of which 165 were treated with CoQ10 and 156 with placebo [5,6,8,9,11,12,17].”
From Effect of Coenzyme Q10 on statin-associated myalgia and adherence to statin therapy: A systematic review and meta-analysis (2020) · cites this paper as [8]
In the citing paper
“Three trials assessed statin continuation at the end of the study period [8,9,11].”
From Effect of Coenzyme Q10 on statin-associated myalgia and adherence to statin therapy: A systematic review and meta-analysis (2020) · cites this paper as [8]
In the citing paper
“Importantly, five studies did not report a washout period and statin rechallenge necessary to confirm that myalgia was related to statin treatment [5,6,8,9,17].”
From Effect of Coenzyme Q10 on statin-associated myalgia and adherence to statin therapy: A systematic review and meta-analysis (2020) · cites this paper as [8]
In the citing paper
“For the second outcome of interest, three studies with 79 CoQ10 treated patients and 78 placebo controlled comparators were included [8,9,11].”
From Effect of Coenzyme Q10 on statin-associated myalgia and adherence to statin therapy: A systematic review and meta-analysis (2020) · cites this paper as [8]
In the citing paper
“A number of these RCTs have reported that CoQ10 reduces SAMS [4-7], while other have failed to demonstrate a benefit [8-12].”
From Effect of Coenzyme Q10 on statin-associated myalgia and adherence to statin therapy: A systematic review and meta-analysis (2020) · cites this paper as [8]
In the citing paper
“A number of studies reported the attrition of patients but did not describe their baseline characteristics or interval outcomes [8,9,11,12].”
From Effect of Coenzyme Q10 on statin-associated myalgia and adherence to statin therapy: A systematic review and meta-analysis (2020) · cites this paper as [8]
In the citing paper
“All included studies were RCTs designed as parallel-group studies with a placebo arm [5,6,8,9,11,12,17].”
From Effect of Coenzyme Q10 on statin-associated myalgia and adherence to statin therapy: A systematic review and meta-analysis (2020) · cites this paper as [8]
In the citing paper
“Qu et al., appears to have misinterpreted the direction of the change in pain score for two included studies [8,12].”
From Effect of Coenzyme Q10 on statin-associated myalgia and adherence to statin therapy: A systematic review and meta-analysis (2020) · cites this paper as [8]
Citations
Cites
Intensive Lipid Lowering with Atorvastatin in Patients with Stable Coronary Disease
LaRosa, J. C., Grundy, S. M., Waters, D. D., Shear, C., Barter, P., Fruchart, J.-C., Gotto, A. M., Greten, H., Kastelein, J. J. P., Shepherd, J., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050461 · Cited by 3,489
HMG-CoA Reductase Inhibitors for Treatment of Hypercholesterolemia
Oates, J. A., Wood, A. J. J., & Grundy, S. M. (1988) · New England Journal of Medicine · doi:10.1056/nejm198807073190105 · Cited by 760
Marbach, E. P., & Weil, M. H. (1967) · PubMed · Cited by 480
Rapid Enzymatic Measurement of Blood Lactate and Pyruvate
Marbach, E. P., & Weil, M. H. (1967) · Clinical Chemistry · doi:10.1093/clinchem/13.4.314 · Cited by 396
Ghirlanda, G., Oradei, A., Manto, A., Lippa, S., Uccioli, L., Caputo, S., Greco, A. V., & Littarru, G. P. (1993) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1993.tb03948.x · Cited by 324
Laaksonen, R., Jokelainen, K., Laakso, J., Sahi, T., Härkönen, M., Tikkanen, M. J., & Himberg, J.-J. (1996) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)89180-1 · Cited by 171
HPLC Analysis of Reduced and Oxidized Coenzyme Q10 in Human Plasma
Tang, P., Miles, M. V., DeGrauw, A. J., Hershey, A. D., & Pesce, A. J. (2001) · Clinical Chemistry · doi:10.1093/clinchem/47.2.256 · Cited by 164
Laaksonen, R., Ojala, J.-P., Tikkanen, M. J., & Himberg, J. (1994) · European Journal of Clinical Pharmacology · doi:10.1007/bf00194398 · Cited by 94
Flint, O. P., Masters, B. A., Gregg, R. E., & Durham, S. K. (1997) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1997.8174 · Cited by 92
Research works printed but not linked: 1
- Kelly, 2005, Coenzyme Q10 improves myopathic pain in statin treated patients, J Am Coll Cardiolol, 45, 3A
Cited by
Sorted by citations
Narrative review: statin-related myopathy
Joy, T. R., & Hegele, R. A. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-12-200906160-00009 · Cited by 453
Coenzyme Q10 Supplementation in Aging and Disease
Hernández‐Camacho, J. D., Bernier, M., López‐Lluch, G., & Navas, P. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00044 · Cited by 391
Statin-induced myopathy: a review and update
Abd, T. T., & Jacobson, T. A. (2011) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2011.540568 · Cited by 320
Clinical aspects of coenzyme Q10: An update
Littarru, G. P., & Tiano, L. (2009) · Nutrition · doi:10.1016/j.nut.2009.08.008 · Cited by 276
Tomaszewski, M., Stępień, K. M., Tomaszewska, J., & Czuczwar, S. J. (2011) · Pharmacological Reports · doi:10.1016/s1734-1140(11)70601-6 · Cited by 224
Statin therapy causes gut dysbiosis in mice through a PXR-dependent mechanism
Caparros-Martin, J. A., Lareu, R. R., Ramsay, J. P., Peplies, J., Reen, F. J., Headlam, H. A., Ward, N. C., Croft, K. D., Newsholme, P., Hughes, J., et al. (2017) · Microbiome · doi:10.1186/s40168-017-0312-4 · Cited by 215
A randomized trial of Coenzyme Q10 in patients with confirmed statin myopathy
Taylor, B. A., Lorson, L., White, C. M., & Thompson, P. D. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.12.016 · Cited by 200
Effects of Coenzyme Q10 on Statin-Induced Myopathy
Banach, M., Serban, C., Sahebkar, A., Ursoniu, S., Rysz, J., Muntner, P., Toth, P. P., Jones, S. R., Rizzo, M., Glasser, S. P., et al. (2015) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2014.08.021 · Cited by 198
Mancini, G. B. J., Baker, S. K., Bergeron, J., FITCHETT, D. H., Frohlich, J. J., Genest, J. J., Gupta, M., Hegele, R. A., Ng, D. S., & Pope, J. E. (2011) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2011.05.007 · Cited by 187
Qu, H., Guo, M., Chai, H., Wang, W., Gao, Z., & Shi, D. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.118.009835 · Cited by 178
Intolerance to Statins: Mechanisms and Management
Bitzur, R., Cohen, H., Kamari, Y., & Harats, D. (2013) · Diabetes Care · doi:10.2337/dcs13-2038 · Cited by 185
Toward “Pain-Free” Statin Prescribing: Clinical Algorithm for Diagnosis and Management of Myalgia
Jacobson, T. A. (2008) · Mayo Clinic Proceedings · doi:10.4065/83.6.687 · Cited by 170
Statins: Adverse reactions, oxidative stress and metabolic interactions
Liu, A., Wu, Q., Guo, J., Arés, I., Rodríguez, J.-L., Martínez‐Larrañaga, M., Yuan, Z., Anadón, A., Wang, X., & Martínez, M. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.10.004 · Cited by 168
Sathasivam, S. (2012) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2012.01.004 · Cited by 149
Mechanisms of statin-associated skeletal muscle-associated symptoms
Bouitbir, J., Sanvee, G. M., Panajatovic, M. V., Singh, F., & Krähenbühl, S. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.03.010 · Cited by 152
Non-adherence to statin therapy: a major challenge for preventive cardiology
Bates, T., Connaughton, V., & Watts, G. F. (2009) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656560903376186 · Cited by 137
Therapeutic use of coenzyme Q 10 and coenzyme Q 10 -related compounds and formulations
Villalba, J. M., Parrado‐Fernández, C., González, M. S., & Alcain, F. J. (2010) · Expert Opinion on Investigational Drugs · doi:10.1517/13543781003727495 · Cited by 139
Primary and secondary coenzyme Q10 deficiency: the role of therapeutic supplementation
Potgieter, M., Pretorius, E., & Pepper, M. S. (2013) · Nutrition Reviews · doi:10.1111/nure.12011 · Cited by 124
Coenzyme Q10, Rosuvastatin, and Clinical Outcomes in Heart Failure
McMurray, J. J. V., Dunselman, P., Wedel, H., Cleland, J. G. F., Lindberg, M., Hjalmarson, Å. C., KJEKSHUS, J. K., Waagstein, F., Apetrei, E., Barrios, V., et al. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.02.075 · Cited by 116
Molecular basis of statin-associated myopathy
Vaklavas, C., Chatzizisis, Y. S., Ziakas, A., Zamboulis, C., & Giannoglou, G. D. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.05.021 · Cited by 115
Mohn, E. S., Kern, H., Saltzman, E. J., Mitmesser, S. H., & McKay, D. L. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics10010036 · Cited by 121
Statin myotoxicity: a review of genetic susceptibility factors
Needham, M., & Mastaglia, F. L. (2014) · Neuromuscular Disorders · doi:10.1016/j.nmd.2013.09.011 · Cited by 108
Hu, M., Cheung, B. M. Y., & Tomlinson, B. (2012) · Therapeutic Advances in Drug Safety · doi:10.1177/2042098612439884 · Cited by 107
Managing the underestimated risk of statin-associated myopathy
Rallidis, L. S., Fountoulaki, K., & ANASTASIOU‐NANA, M. I. (2011) · International Journal of Cardiology · doi:10.1016/j.ijcard.2011.07.048 · Cited by 99
Effect of Coenzyme Q10 supplementation on statin-induced myalgias
Bookstaver, D. A., Burkhalter, N. A., & Hatzigeorgiou, C. (2012) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2012.04.026 · Cited by 89
Mullen, P. J., Lüscher, B., Scharnagl, H., Krähenbühl, S., & Brecht, K. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.12.007 · Cited by 88
Coenzyme Q10: is there a clinical role and a case for measurement?
Molyneux, S. L., Young, J. M., Florkowski, C. M., Lever, M., & George, P. M. (2008) · PubMed Central · Cited by 87
Bergamini, C., Moruzzi, N., Sblendido, A., Lenaz, G., & Fato, R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033712 · Cited by 84
Statin-Associated Muscle Disease: Advances in Diagnosis and Management
Taylor, B. A., & Thompson, P. D. (2018) · Neurotherapeutics · doi:10.1007/s13311-018-0670-z · Cited by 85
Coenzyme Q deficiency in muscle
Trevisson, E., DiMauro, S., Navas, P., & Salviati, L. (2011) · Current Opinion in Neurology · doi:10.1097/wco.0b013e32834ab528 · Cited by 78
The molecular genetics of coenzyme Q biosynthesis in health and disease
Laredj, L. N., Licitra, F., & Puccio, H. M. (2013) · Biochimie · doi:10.1016/j.biochi.2013.12.006 · Cited by 78
Evidence-Based Management of Statin Myopathy
Harper, C. R., & Jacobson, T. A. (2010) · Current Atherosclerosis Reports · doi:10.1007/s11883-010-0120-9 · Cited by 77
From Mitochondria to Atherosclerosis: The Inflammation Path
Suarez-Rivero, J. M., Pastor‐Maldonado, C. J., Povea-Cabello, S., Álvarez-Córdoba, M., Villalón-García, I., Talaverón-Rey, M., Suárez-Carrillo, A., Munuera-Cabeza, M., & Sánchez-Alcázar, J. A. (2021) · Biomedicines · doi:10.3390/biomedicines9030258 · Cited by 78
Suksomboon, N., Poolsup, N., & Juanak, N. (2015) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/jcpt.12280 · Cited by 77
Šabovič, M. (2014) · Medical Science Monitor · doi:10.12659/msm.890777 · Cited by 75
Molecular mechanisms of statin intolerance
Gluba-Brzózka, A., Franczyk, B., Toth, P. P., Rysz, J., & Banach, M. (2016) · Archives of Medical Science · doi:10.5114/aoms.2016.59938 · Cited by 73
Effects of ubiquinone (coenzyme Q10) on myopathy in statin users
Schaars, C. F., & Stalenhoef, A. F. H. (2008) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3283168ecd · Cited by 74
Klopstock, T. (2008) · Current Opinion in Neurology · doi:10.1097/wco.0b013e32830e2774 · Cited by 70
Venero, C. V., & Thompson, P. D. (2009) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2008.11.002 · Cited by 68
The spectrum of statin myopathy
Mohassel, P., & Mammen, A. L. (2013) · Current Opinion in Rheumatology · doi:10.1097/01.bor.0000434673.85515.89 · Cited by 69
Compliance with lipid-lowering therapy and its impact on cardiovascular morbidity and mortality
Liberopoulos, E. N., Florentin, M., Mikhailidis, D. P., & Elisaf, M. (2008) · Expert Opinion on Drug Safety · doi:10.1517/14740330802396984 · Cited by 68
Muscle Toxicity of Drugs: When Drugs Turn Physiology into Pathophysiology
Janssen, L., Allard, N. A. E., Saris, C. G. J., Keijer, J., Hopman, M. T. E., & Timmers, S. (2019) · Physiological Reviews · doi:10.1152/physrev.00002.2019 · Cited by 71
Feng, Q., Wilke, R. A., & Baye, T. M. (2012) · Pharmacogenomics · doi:10.2217/pgs.12.11 · Cited by 64
Protective Effects of Antioxidants in Huntington’s Disease: an Extensive Review
Essa, M. M., Moghadas, M., Ba-Omar, T., Qoronfleh, M. W., Guillemin, G. J., Manivasagam, T., Justin‐Thenmozhi, A., Ray, B., Bhat, A., Chidambaram, S. B., et al. (2019) · Neurotoxicity Research · doi:10.1007/s12640-018-9989-9 · Cited by 68
Mechanisms of statin-induced myalgia assessed by physiogenomic associations
Ruaño, G., Windemuth, A., Wu, A. H. B., Kane, J. P., Malloy, M. J., Pullinger, C. R., Kocherla, M., Bogaard, K., Gordon, B. R., Holford, T. R., et al. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.07.007 · Cited by 66
Co-enzyme Q10 supplementation for the primary prevention of cardiovascular disease
Flowers, N., Hartley, L., Todkill, D., Stranges, S., & Rees, K. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010405.pub2 · Cited by 64
Statins and skeletal muscles toxicity: From clinical trials to everyday practice
Norata, G. D., Tibolla, G., & Catapano, A. L. (2014) · Pharmacological Research · doi:10.1016/j.phrs.2014.04.012 · Cited by 66
CoQ10Function and Role in Heart Failure and Ischemic Heart Disease
Ayer, A., Macdonald, P. S., & Stocker, R. (2015) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071714-034258 · Cited by 65
Brown, W. V. (2008) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e328319baba · Cited by 60
Statin-Associated Myopathy: From Genetic Predisposition to Clinical Management
Vrablı́k, M., Zlatohlávek, L., Štulc, T., Adámková, V., Prusíková, M., Schwarzová, L., Hubacek, J. A., & Češka, R. (2014) · Physiological Research · doi:10.33549/physiolres.932865 · Cited by 59
Overcoming toxicity and side-effects of lipid-lowering therapies
Wilkinson, M. J., Laffin, L. J., & Davidson, M. H. (2014) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2014.01.006 · Cited by 56
Clinical characterization and molecular mechanisms of statin myopathy
Toth, P. P., Harper, C. R., & Jacobson, T. A. (2008) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.6.7.955 · Cited by 55
Kennedy, C., Köller, Y., & Surkova, E. (2020) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2020.03.006 · Cited by 51
No effect of combined coenzyme Q10 and selenium supplementation on atorvastatin-induced myopathy
Bogsrud, M. P., Langslet, G., Ose, L., Arnesen, K.-E., Sm stuen, M. C., Malt, U. F., Woldseth, B., & Retterstøl, K. (2013) · Scandinavian Cardiovascular Journal · doi:10.3109/14017431.2012.756119 · Cited by 53
Muscle-related side-effects of statins
Taylor, B. A., & Thompson, P. D. (2015) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000174 · Cited by 53
Coenzyme Q10: A therapy for hypertension and statin-induced myalgia?
Wyman, M. J., Leonard, M. C., & Morledge, T. J. (2010) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.77a.09078 · Cited by 52
Support of drug therapy using functional foods and dietary supplements: focus on statin therapy
Eussen, S. R. B. M., Klungel, O. H., Garssen, J., Verhagen, H., van Kranen, H. J., Loveren, H. V., & Rompelberg, C. J. M. (2010) · British Journal Of Nutrition · doi:10.1017/s0007114509993230 · Cited by 52
Coenzyme Q10 and Statin Myalgia: What is the Evidence?
Mas, E., & Mori, T. A. (2010) · Current Atherosclerosis Reports · doi:10.1007/s11883-010-0134-3 · Cited by 43
The effects of statins on exercise and physical activity
Noyes, A. M., & Thompson, P. D. (2017) · Journal of clinical lipidology · doi:10.1016/j.jacl.2017.07.003 · Cited by 44
Cell Rearrangement and Oxidant/Antioxidant Imbalance in Huntington’s Disease
D’Egidio, F., Castelli, V., Cimini, A., & d’Angelo, M. (2023) · Antioxidants · doi:10.3390/antiox12030571 · Cited by 42
Keen, H. I., Krishnarajah, J., Bates, T. R., & Watts, G. F. (2014) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2014.937422 · Cited by 40
Dietary supplements and cardiovascular diseases
Durante, A., & Bronzato, S. (2018) · International Journal of Preventive Medicine · doi:10.4103/ijpvm.ijpvm_179_17 · Cited by 40
Thompson, P. D., Parker, B. A., Clarkson, P. M., Pescatello, L. S., White, C. M., Grimaldi, A. S., Levine, B. D., Haller, R. G., & Hoffman, E. P. (2010) · Preventive Cardiology · doi:10.1111/j.1751-7141.2009.00063.x · Cited by 37
Potential metabolic consequences of statins in sepsis*
Brealey, D. A., Singer, M., & Terblanche, M. (2011) · Critical Care Medicine · doi:10.1097/ccm.0b013e31820eb74f · Cited by 36
Liu, Z., Tian, Z., Zhao, D., Liang, Y. J., Dai, S., Liu, M., Hou, S., Dong, X., Zhaxinima, Z., & Yang, Y. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac585 · Cited by 39
Deichmann, R. E., Lavie, C. J., Asher, T., DiNicolantonio, J. J., O’Keefe, J. H., & Thompson, P. D. (2015) · Europe PMC (PubMed Central) · Cited by 35
Enas, E. A., Kuruvila, A. T., Khanna, P., Pitchumoni, C. S., & Mohan, V. (2013) · Europe PMC (PubMed Central) · Cited by 34
A randomized trial of coenzyme Q10 in patients with statin myopathy: Rationale and study design
Parker, B. A., Gregory, S. M., Lorson, L., Polk, D. M., White, C. M., & Thompson, P. D. (2013) · Journal of clinical lipidology · doi:10.1016/j.jacl.2013.02.002 · Cited by 33
Prosarcopenic Effects of Statins May Limit Their Effectiveness in Patients with Heart Failure
Bielecka-Dabrowa, A. M., Fabiś, J., Mikhailidis, D. P., von Haehling, S., Sahebkar, A., Rysz, J., & Banach, M. (2018) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2018.02.003 · Cited by 30
Bandyopadhyay, D., Ashish, K., Hajra, A., Qureshi, A., & Ghosh, R. K. (2018) · Journal of Lipids · doi:10.1155/2018/3179201 · Cited by 32
Dohlmann, T. L., Kuhlman, A. B., Morville, T., Dahl, M., Asping, M., Orlando, P., Silvestri, S., Tiano, L., Helge, J. W., Dela, F., et al. (2022) · Antioxidants · doi:10.3390/antiox11091698 · Cited by 31
Avis, H. J., Hargreaves, I., Ruiter, J. P. N., Land, J. M., Wanders, R. J. A., & Wijburg, F. A. (2010) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2010.08.015 · Cited by 31
Clementino, A., & Sonvico, F. (2018) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2018.03.046 · Cited by 31
Shi, Z., & Han, S. (2025) · Heliyon · doi:10.1016/j.heliyon.2025.e41629 · Cited by 37
The Biomedical Importance of the Missing Pathway for Farnesol and Geranylgeraniol Salvage
Verdaguer, I. B., Crispim, M., Hernández, A., & Katzin, A. M. (2022) · Molecules · doi:10.3390/molecules27248691 · Cited by 29
Emerging lipid-lowering drugs: squalene synthase inhibitors
Elsayed, R. K., & Evans, J. D. (2008) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.13.2.309 · Cited by 29
Atorvastatin-induced cell toxicity in yeast is linked to disruption of protein isoprenylation
Callegari, S., McKinnon, R. A., Andrews, S., & de Barros Lopes, M. A. (2010) · FEMS Yeast Research · doi:10.1111/j.1567-1364.2009.00593.x · Cited by 28
Pagano, G., Talamanca, A. A., Castello, G., Cordero, M. D., d’Ischia, M., Gadaleta, M. N., Pallardó, F. V., Petrović, S. Ž., Tiano, L., & Zatterale, A. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms151120169 · Cited by 26
Statins’ effect on plasma levels of Coenzyme Q10 and improvement in myopathy with supplementation
Littlefield, N., Beckstrand, R. L., & Luthy, K. E. (2013) · Journal of the American Association of Nurse Practitioners · doi:10.1002/2327-6924.12046 · Cited by 27
Is there a place for coenzyme Q in the management of metabolic disorders associated with obesity?
Sohet, F. M., & Delzenne, N. M. (2012) · Nutrition Reviews · doi:10.1111/j.1753-4887.2012.00526.x · Cited by 27
Wei, H., Xin, X., Zhang, J., Xie, Q., Naveed, M., Kaiyan, C., & Xiao, P. (2021) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-021-02651-x · Cited by 24
CoQ10 and L-carnitine for statin myalgia?
DiNicolantonio, J. J. (2012) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.12.92 · Cited by 23
Statin Myopathy: A Lipid Clinic Experience on the Tolerability of Statin Rechallenge
Fung, E. C., & Crook, M. A. (2012) · Cardiovascular Therapeutics · doi:10.1111/j.1755-5922.2011.00267.x · Cited by 34
Statins and the neuromuscular system: a neurologist's perspective
Argov, Z. (2014) · European Journal of Neurology · doi:10.1111/ene.12604 · Cited by 22
Taylor, B. A. (2017) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-017-0251-2 · Cited by 22
Prooxidative toxicity and selenoprotein suppression by cerivastatin in muscle cells
Fuhrmeister, J., Tews, M., Kromer, A., & Moosmann, B. (2012) · Toxicology Letters · doi:10.1016/j.toxlet.2012.10.010 · Cited by 21
Statins and Neuropathic Pain: A Narrative Review
Pergolizzi, J. V., Magnusson, P., LeQuang, J. A., Razmi, R., Zampogna, G., & Taylor, R. (2020) · Pain and Therapy · doi:10.1007/s40122-020-00153-9 · Cited by 22
The effect of coenzyme Q10 in statin myopathy.
Zlatohlávek, L., Vrablı́k, M., Grauová, B., Motyková, E., & Češka, R. (2012) · PubMed · Cited by 21
Alcocer‐Gómez, E., Cano‐García, F. J., & Cordero, M. D. (2013) · Nutrition · doi:10.1016/j.nut.2013.05.005 · Cited by 21
How do you treat patients with myalgia who take statins?
Siddiqi, S., & Thompson, P. D. (2008) · Current Atherosclerosis Reports · doi:10.1007/s11883-009-0002-1 · Cited by 20
Farrag, S. M., Hamzawy, M. A., El-Yamany, M. F., Saad, M. A., & Nassar, N. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.04.034 · Cited by 19
Strategies to preserve the use of statins in patients with previous muscular adverse effects
Reinhart, K. M., & Woods, J. A. (2012) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp100700 · Cited by 18
Schweitzer, A. M., Gingrich, M. A., Hawke, T. J., & Rebalka, I. A. (2020) · European Journal of Applied Physiology · doi:10.1007/s00421-020-04360-2 · Cited by 22
Coenzyme Q10 Supplementation for the Treatment of statin-associated Muscle Symptoms
Chen, W., Ochs‐Balcom, H. M., Ma, C., Isackson, P. J., Vladutiu, G. D., & Luzum, J. A. (2022) · Future Cardiology · doi:10.2217/fca-2021-0106 · Cited by 17
Interactions of commonly used dietary supplements with cardiovascular drugs: a systematic review
Kanji, S., Seely, D., Yazdi, F., Tetzlaff, J., Singh, K., Tsertsvadze, A., Tricco, A. C., Sears, M., Ooi, T. C., Turek, M. A., et al. (2012) · Systematic Reviews · doi:10.1186/2046-4053-1-26 · Cited by 17
Efficiency of hepatocyte pretreatment with coenzyme Q10 against statin toxicity
Eghbal, M. A., Abdoli, N., & Azarmi, Y. (2014) · Archives of Industrial Hygiene and Toxicology · doi:10.2478/10004-1254-65-2014-2398 · Cited by 16
Mammen, A. L. (2013) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/01.con.0000440663.26427.f4 · Cited by 15
Non-traditional Dosing of Statins in Statin-Intolerant Patients—Is It Worth a Try?
Cornier, M., & Eckel, R. H. (2014) · Current Atherosclerosis Reports · doi:10.1007/s11883-014-0475-4 · Cited by 14
A Clinical Review of Statin-Associated Myopathy
Shannon, J. A., John, S. M., Parihar, H. S., Allen, S. N., & Ferrara, J. J. (2013) · Journal of Pharmacy Technology · doi:10.1177/8755122513500915 · Cited by 14
Coenzyme Q10 and Xenobiotic Metabolism: An Overview
Mantle, D., & Golomb, B. A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26125788 · Cited by 13
Metadata
- Authors
- Young, J. M., Florkowski, C. M., Molyneux, S. L., McEwan, R. G., Frampton, C. M., George, P. M., & Scott, R. S.
- Affiliations
- Christchurch Hospital (NZ)
- Canterbury Health Laboratories (NZ)
- Corresponding author
- Young, Joanna M.
- ORCID
- Venue
- The American Journal of Cardiology
- Publisher
- Elsevier BV
- Published
- 2007-11
- Volume
- 100
- Issue
- 9
- Pages
- 1400-1403
- ISSN
- 0002-9149 (ISSN-L)
- OpenAlex
- W1993325964
- Cited by
- 185
- References
- 21
- Citations by year
- 2026: 2 · 2025: 5 · 2024: 2 · 2023: 1 · 2022: 5 · 2021: 3 · 2020: 5 · 2019: 3 · 2018: 13 · 2017: 11 · 2016: 8 · 2015: 11 · 2014: 16 · 2013: 19 · 2012: 22
- FWCI
- 5.93
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The American Journal of Cardiology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Coenzyme Q10 studies and effects
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Complementary and alternative medicine › Complementary and Alternative Medicine Studies
- Keywords
- coenzyme Q10, simvastatin, statin-induced myalgia, statin intolerance, mitochondrial dysfunction, statin dose titration, statin adverse effects
- MeSH terms
- Coenzymes, Double-Blind Method, Drug Tolerance, Female, Humans, Male, Middle Aged, Muscular Diseases, Pilot Projects, Ubiquinone, Vitamins, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Simvastatin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
